• Fetck KC Callout
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 Insights™
dvm360 LIVE!™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Zoetis donates over 11,000 COVID-19 vaccines to high-risk zoo animals

July 8, 2021
dvm360 Staff
dvm360, dvm360 August 2021, Volume 52,

The vaccine was distributed to over 70 different zoos and dozens of animal welfare organizations to help preserve the health and well-being of zoo animals.

To continue the tremendous strides being made amid the ongoing COVID-19 pandemic, Zoetis has graciously donated more than 11,000 doses of its experimental COVID-19 vaccine to safeguard the health of over 100 mammalian species.

The vaccine deployment follows the company’s response to a request made in January by the San Diego Zoo confirming COVID-19 cases in the gorillas at its San Diego Zoo Safari Park. Among the first to receive the shipment and 2 doses were tigers, black bears, grizzly bears, mountain lions, and ferrets from the Oakland Zoo in Northern California.

“We are proud that our innovative research and development work and vaccine donations can help veterinary professionals within the zoo community continue to provide a high standard of care to the primates, big cats, and many other species they care for and reduce the risk of COVID-19,” says Mike McFarland, DVM, DABVP, chief medical officer at Zoetis, in a company release.

The vaccine received authorization for experimental use on a case-by-case basis by the United States Department of Agriculture (USDA) and appropriate state veterinarians. Once approved, it was then distributed to nearly 70 zoos and dozens of conservatories, sanctuaries, academic institutions, and government organizations located in 27 states.

With its headquarters located in Kalamazoo, Michigan, the Zoetis research and development team channeled its decades of experience in developing other coronavirus vaccines for domesticated animals to curate the COVID-19 vaccine. Though the antigen is the same seen in human vaccines, vaccines for animals focus on the carrier (adjuvant) that is used, thus the combination of both the antigen and carrier guarantees the safety for animals that receive it.

Additionally, Zoetis has also begun developing feline and canine-specific real-time Polymerase Chain Reaction (PCR) diagnostic tests to better detect SARS-CoV-2.

“When the first dog was infected with COVID-19 in Hong Kong last year, we immediately began to work on a vaccine that could be used in domestic animals, and in eight months we completed our initial safety studies, which we presented at the World One Health Congress last year. While thankfully a COVID-19 vaccine is not needed in pets or livestock at this time, we are proud that our work can help zoo animals at risk of COVID-19,” says Mahesh Kumar, senior VP of global biologics at Zoetis.

“More than ever before, the COVID-19 pandemic put a spotlight on the important connection between animal health and human health, and we continue to monitor for emerging infectious diseases that can impact animals as well as people,” he adds.

To learn more about Zoetis and its mission, go here.

download issueDownload Issue: dvm360 August 2021

Related Content:

One HealthMedicalTechniciansAssociatesRolesAnimal Welfaredvm360 August 2021
Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award
Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award
A deep dive into rabbit gastrointestinal stasis syndrome
A deep dive into rabbit gastrointestinal stasis syndrome
Learn practical toxicology with Renee Schmid at Fetch Kansas City
Learn practical toxicology with Renee Schmid at Fetch Kansas City

Latest News

Are you ready for the Fetch dvm360® Kansas City Block Party?

Mini donkey successfully receives pacemaker to manage fatal heart condition

News wrap-up: This week’s headlines, plus Cincinnati Zoo welcomes baby hippo

Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award

View More Latest News